Former Mexican president and cannabis-legalization activist, Vicente Fox, has noticed that the governments in Latin America are legalizing the use of cannabis, a plant that was once shunned by many countries. As Latin America embraces cannabis, Fox is keen to see Khiron Life Sciences Corp. (TSXV:KHRN), the Canadian cannabis company on which he is a board member, be a cannabis supplier to the 640 million people that reside in the area, according to an article by Bloomberg. To date, 10 governments in Latin America and the Caribbean have passed legalization. Mexico is poised to join others in the region and legalize, which is keeping Khiron busy as they work on establishing themselves in each area as countries finalize their regulations.

“We have a new world,” said Fox. “It’s surprising for an activity that was in the hands of criminals, illegality and the underworld. The paradigm has totally changed.”

Khiron will be launching sales throughout Latin America this year and is currently selling products in Colombia. Medical cannabis sales in the region are expected to reach $15 million by 2025, according to an estimate by BMO Capital Markets. Additionally, they have recently entered into a joint venture with Colorado-based Dixie Brands Inc. (CSE:DIXI.U) to market a line of medicinal products with cannabis cultivated in four countries in the region. Under the joint venture, Khiron will be supplying the product and obtain the necessary approvals and licenses, and Dixie Brands will provide the formulas and brands.

To read the full article, click here.

Click here to connect with Khiron Life Sciences Corp. (TSXV:KHRN) for an Investor Presentation.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less